Characterization of Inhibitory Effect of Carbapenem Antibiotics on the Deconjugation of Valproic Acid Glucuronide-Reference-Cited by-同舟云学术

Characterization of Inhibitory Effect of Carbapenem Antibiotics on the Deconjugation of Valproic Acid Glucuronide

Published:2010-06-25 Issue:10 Volume:38 Page:1828-1835
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Masuo Yusuke,Ito Kousei,Yamamoto Takehito,Hisaka Akihiro,Honma Masashi,Suzuki Hiroshi

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference30 articles.

1. Steady-state dispositions of valproate and diflunisal alone and coadministered to healthy volunteers

2. Safety and efficacy of divalproex sodium monotherapy in partial epilepsy: a double-blind, concentration-response design clinical trial. Depakote Monotherapy for Partial Seizures Study Group;Beydoun;Neurology,1997

3. Potent and selective inactivation of human liver microsomal cytochrome P-450 isoforms by L-754,394, an investigational human immune deficiency virus protease inhibitor;Chiba;J Pharmacol Exp Ther,1995

4. Pharmacokinetic interaction between valproic acid and meropenem

5. Acute Seizures Due to a Probable Interaction between Valproic Acid and Meropenem

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Clinical Nomogram for Predicting Substandard Serum Valproic Acid Concentration In Chinese Epilepsy Patients;2024

2. Clinical impact of carbapenems in critically ill patients with valproic acid therapy: A propensity-matched analysis;Frontiers in Neurology;2023-03-09

3. A carbapenem antibiotic inhibiting a mammalian serine protease: structure of the acylaminoacyl peptidase–meropenem complex;Chemical Science;2022

4. A Retrospective Case Series of Concomitant Carbapenem and Valproic Acid Use: Are Best Practice Advisories Working?;Journal of Pharmacy Practice;2021-12-27

5. Classification of drugs for evaluating drug interaction in drug development and clinical management;Drug Metabolism and Pharmacokinetics;2021-12